Use of F-18 Fluorodeoxyglucose Positron Emission Tomography With Dual-Phase Imaging to Identify Intraductal Papillary Mucinous Neoplasm

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 2, 2013, Pages 181-186

  Saito, Masayoshi ^a   Ishihara, Takeshi ^a   Tada, Motohisa ^a   Tsuyuguchi, Toshio ^a   Mikata, Rintaro ^a   Sakai, Yuji ^a   Tawada, Katsunobu ^a   Sugiyama, Harutoshi ^a   Kurosawa, Jo ^a   Otsuka, Masayuki ^a   Uchida, Yoshitaka ^b   Uchiyama, Katsuhiro ^b   Miyazaki, Masaru ^a   Yokosuka, Osamu ^a  

^a CHIBA UNIVERSITY   (Japan)

^b Sannou Hospital Medical Center   (Japan)

Author keywords

Carcinoma; Comparison; ; Diagnosis; ; Imaging; ; Pancreas;

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONSENSUS; DIAGNOSTIC ACCURACY; EARLY CANCER; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGING; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE;

ADENOCARCINOMA, MUCINOUS; AGED; AGED, 80 AND OVER; CARCINOMA, PANCREATIC DUCTAL; DIAGNOSTIC IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SENSITIVITY AND SPECIFICITY;

EID: 84872405041     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.10.037     Document Type: Article

References (29)

1. Ohhashi K., Murakami Y., Maruyama M., et al. Four cases of mucus-secreting pancreatic cancer. Prog Dig Endosc 1982, 20:348-351.
2. Kloppel G., Solcia E., Longnecker D.S., et al. Histological typing of tumors of the exocrine pancreas. World Health Organization: international histological classification of tumours 1996, 15-21. Springer, Berlin, Germany. 2nd ed.
3. Goh B.K., Tan Y.M., Cheow P.C., et al. Cystic neoplasms of the pancreas with mucin-production. Eur J Surg Oncol 2005, 31:282-287.
4. Salvia R., Fernández-del Castillo C., Bassi C., et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004, 239:678-685.
5. Sugiyama M., Izumisato Y., Abe N., et al. Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas. Br J Surg 2003, 90:1244-1249.
6. Terris B., Ponsot P., Paye F., et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000, 24:1372-1377.
7. Sohn T.A., Yeo C.J., Cameron J.L., et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004, 239:788-797.
8. Kitagawa Y., Unger T.A., Taylor S., et al. Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous tumor of the pancreas. J Gastrointest Surg 2003, 7:12-19.
9. Matsumoto T., Aramaki M., Yada K., et al. Optimal management of the branch duct type intraductal papillary mucinous neoplasms of the pancreas. J Clin Gastroenterol 2003, 36:261-265.
10. Yamao K., Ohashi K., Nakamura T., et al. The prognosis of intraductal papillary mucinous tumors of the pancreas. Hepatogastroenterology 2000, 47:1129-1134.
11. Tanaka M., Chari S., Adsay V., et al. International Consensus Guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006, 6:17-32.
12. Sperti C., Bissoli S., Pasquali C., et al. 18-Fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2007, 246:932-937.
13. Tomimaru Y., Takeda Y., Tatsumi M., et al. Utility of 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography in differential diagnosis of benign and malignant intraductal papillary-mucinous neoplasm of the pancreas. Oncol Rep 2010, 24:613-620.
14. Takanami K., Hiraide T., Tsuda M., et al. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules. Ann Nucl Med 2011, 25:501-510.
15. Hong H.S., Yun M., Cho A., et al. The utility of F-18 FDG PET/CT in the evaluation of pancreatic intraductal papillary mucinous neoplasm. Clin Nucl Med 2010, 35:776-779.
16. Shreve P.D. Focal fluorine-18 fluorodeoxyglucose accumulation in inflammatory pancreatic disease. Eur J Nucl Med 1998, 25:259-264.
17. Matthies A., Hickeson M., Cuchiara A., et al. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. J Nucl Med 2002, 43:871-875.
18. Kubota K., Itoh M., Ozaki K., et al. Advantage of delayed whole-body FDG-PET imaging for tumor detection. Eur J Nucl Med 2001, 28:696-703.
19. Zhuang H., Pourdehnad M., Lambright E.S., et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001, 42:1412-1417.
20. Bosman F.T., Carneiro F., Hruban R.H., et al. WHO classification of tumours of the digestive system 2010, IARC Press, Lyon, France.
21. Nakamoto Y., Higashi T., Sakahara H., et al. Delayed (18)F-fluoro-2-deoxy-D-glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas. Cancer 2000, 89:2547-2554.
22. Okano K., Kakinoki K., Akamoto S., et al. 18F-fluorodeoxyglucose positron emission tomography in the diagnosis of small pancreatic cancer. World J Gastroenterol 2011, 17:231-235.
23. Tang R.S., Weinberg B., Dawson D.W., et al. Evaluation of the guidelines for management of pancreatic branch-duct intraductal papillary mucinous neoplasm. Clin Gastroenterol Hepatol 2008, 6:815-819.
24. Pelaez-Luna M., Chari S.T., Smyrk T.C., et al. Do consensus indications for resection in branch duct intraductal papillary mucinous neoplasm predict malignancy?. A study of 147 patients. Am J Gastroenterol 2007, 102:1759-1764.
25. Baba T., Yamaguchi T., Ishihara T., et al. Distinguishing benign from malignant intraductal papillary mucinous tumors of the pancreas by imaging techniques. Pancreas 2004, 29:212-217.
26. Kubo H., Nakamura K., Itaba S., et al. Differential diagnosis of cystic tumors of the pancreas by endoscopic ultrasonography. Endoscopy 2009, 41:684-689.
27. Nakagawa A., Yamaguchi T., Ohtsuka M., et al. Usefulness of multidetector computed tomography for detecting protruding lesions in intraductal papillary mucinous neoplasm of the pancreas in comparison with single-detector computed tomography and endoscopic ultrasonography. Pancreas 2009, 38:131-136.
28. Guarise A., Faccioli N., Ferrari M., et al. Evaluation of serial changes of pancreatic branch duct intraductal papillary mucinous neoplasms by follow-up with magnetic resonance imaging. Cancer Imaging 2008, 8:220-228.
29. Baiocchi G.L., Portolani N., Bertagna F., et al. Possible additional value of 18FDG-PET in managing pancreas intraductal papillary mucinous neoplasms: preliminary results. J Exp Clin Cancer Res 2008, 27:10.